Penny stock from lower circuit to upper circuit after kicking off FY26 with Rs 464.88 lakh PAT in Q1, Surpassing & doubling FY25 profit and driving expansion plans!

DSIJ Intelligence-1 / 11 Aug 2025/ Categories: Multibaggers, Penny Stocks, Trending

Penny stock from lower circuit to upper circuit after kicking off FY26 with Rs 464.88 lakh PAT in Q1, Surpassing & doubling FY25 profit and driving expansion plans!

The stock is up by 59 per cent from its 52-week low and has given multibagger returns of over 500 per cent in 5 years.

Remedium Lifecare Ltd, a burgeoning entity in the pharmaceutical supply chain and speciality chemicals domain, has announced a robust start to Fiscal Year 2026, reporting a significant Profit After Tax (PAT) of Rs 464.88 lakhs for the quarter ended June 30, 2025. This marks a substantial turnaround from the Rs 204.60 lakhs loss recorded in the preceding quarter (Q4FY25). This impressive Q1 PAT not only signifies a sharp rebound in profitability but also remarkably surpasses the company's total PAT for the entire Fiscal Year 2025, which stood at Rs 212.94 lakh.

During the first quarter of FY26, Remedium Lifecare generated revenue from operations of Rs 11,336.67 lakh. The company's Profit Before Tax (PBT) reached Rs 571.23 lakhs, demonstrating effective cost management and enhanced operational efficiencies. This strong financial performance underscores the company's successful strategic execution and resilience, positioning it for sustained growth in the upcoming quarters.

With its first-quarter PAT more than doubling the total profit of the previous fiscal year, Remedium Lifecare is exceptionally well-positioned for continued expansion. The company aims to fuel this growth through innovation-led strategies and ambitious market expansion plans, building on the significant operational momentum demonstrated in its latest financial results.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, download the service details here.

About the Company

Founded in 1988, Remedium Lifecare Ltd. is a BSE-listed pharmaceutical company engaged in the trading and distribution of raw materials as a supply chain management for the pharmaceutical industry with an emphasis on quality, compliance and global reach. The company continues to expand its presence while playing a pivotal role in India’s pharmaceutical ecosystem.

Remedium Lifecare Ltd has a market cap of over Rs 100 crore. According to the shareholding pattern, the company's promoters own only a 1.13 per cent stake in the company and the maximum stake is owned by the public shareholders, i.e. 98.87 per cent stake. The stock is up by 59 per cent from its 52-week low and has given multibagger returns of over 500 per cent in 5 years.

Disclaimer: The article is for informational purposes only and not investment advice.